One of the "Healthy Skepticism" campaign print ads (Eli Lilly ... medicine” plus a tool to help verify whether a Mounjaro or Zepbound package is legitimate.

The print ads claim that “skepticism is essential to making medicine ... reliable developer and distributor of its approved weight loss drugs — Mounjaro and Zepbound — by contrasting them to ...

At the 2024 Academy Awards, Eli Lilly, the manufacturer of blockbuster weight loss drugs including Mounjaro and Zepbound ... print campaign urging people to “Check Before You Inject.” The ad ...

Copycat versions of Eli Lilly’s diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They’re ...

The makers of weight-loss drugs Wegovy and Zepbound are lowering prices significantly, effective immediately, to make them more affordable.

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now. By Rebecca Robbins It’s easy to make a medical case for ...

The ad space in print media saw a marginal 1% rise in 2024 compared to 2023, with more than 78,000 advertisers and 1.04 lakh brands investing in print advertising, according to the latest TAM AdEx ...

TAM AdEx India has released ‘A Glimpse into Advertising Trends for Y 2024’ for print advertising. The report details the print AdEx trends for the year, highlighting valuable insights for ...

A new study suggests blockbuster weight loss drugs Wegovy and Zepbound are not cost-effective at their current prices, despite the proven health benefits. The study, published in JAMA Health Forum ...